Promoter methylation is clearly involved in the inactivation of CD133 gene in numerous tumors and cancer cell lines [20, 21], but regulation of CD133 expression is a more complex phenomenon in which abnormal methylation of the promoter is not the only determining factor [21, 36, 37]. The gene discussed is PROM1; the disease is cancer.